Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiyuki Yoneda

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Clinical Calcium|July 5, 2005
[Mechanism and treatment of cancer metastasis to bone]Toshiyuki Yoneda
Clinical Calcium|March 19, 2005
[Not Available]Toshiyuki Yoneda
Clinical Calcium|May 7, 2010
[Secondary osteoporosis UPDATE. Pathophysiology and management of cancer treatment-induced bone loss/fractures]Toshiyuki Yoneda
Clinical Calcium|August 5, 2011
[Involvement of RANKL/RANK pathway in bone metastasis in breast cancer]Toshiyuki Yoneda
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2011
[Mechanism and strategy for treatment of cancer metastasis to bone]Toshiyuki Yoneda
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 25, 2012
[Treatment of bone metastasis by denosumab, the human monoclonal neutralizing antibody to RANKL]Toshiyuki Yoneda
Clinical Calcium|March 19, 2005
[Role of cell adhesion molecules in bone metastasis]Toshiyuki Yoneda
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 16, 2011
[Anti-RANKL antibody for the management of bone metastasis]Toshiyuki Yoneda
Clinical Calcium|March 28, 2012
[Relationship between maintaining whole-body homeostasis and dental diseases]Toshiyuki Yoneda
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 2002
[Stimulation of bone formation by anti-hyperlipidemic agent statins and its mechanism of action]Toshiyuki Yoneda
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Clinical Calcium|July 5, 2005
[Mechanism and treatment of cancer metastasis to bone]Toshiyuki Yoneda
Clinical Calcium|March 19, 2005
[Not Available]Toshiyuki Yoneda
Clinical Calcium|May 7, 2010
[Secondary osteoporosis UPDATE. Pathophysiology and management of cancer treatment-induced bone loss/fractures]Toshiyuki Yoneda
Clinical Calcium|August 5, 2011
[Involvement of RANKL/RANK pathway in bone metastasis in breast cancer]Toshiyuki Yoneda
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2011
[Mechanism and strategy for treatment of cancer metastasis to bone]Toshiyuki Yoneda
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 25, 2012
[Treatment of bone metastasis by denosumab, the human monoclonal neutralizing antibody to RANKL]Toshiyuki Yoneda
Clinical Calcium|March 19, 2005
[Role of cell adhesion molecules in bone metastasis]Toshiyuki Yoneda
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 16, 2011
[Anti-RANKL antibody for the management of bone metastasis]Toshiyuki Yoneda
Clinical Calcium|March 28, 2012
[Relationship between maintaining whole-body homeostasis and dental diseases]Toshiyuki Yoneda
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 2002
[Stimulation of bone formation by anti-hyperlipidemic agent statins and its mechanism of action]Toshiyuki Yoneda
Pageof 14